Daily Newsletter

24 November 2023

Daily Newsletter

24 November 2023

NSW government launches GoodSAM app for cardiac arrest patients

The app encourages community members to register as responders who can perform chest compressions until paramedics arrive.

November 23 2023

The government of New South Wales (NSW), Australia, has launched a mobile app for individuals experiencing cardiac arrest in partnership with NSW Ambulance.

The GoodSAM app aims to increase cardiac arrest survival rates by encouraging community members to register as responders who can perform cardiopulmonary rescuscitation (CPR) until paramedics arrive.

Integrated with the Triple Zero (000) dispatch system, it alerts nearby volunteers when someone requires CPR. The Emergency Medical Call Taker can then guide them through the process.

Four lives were saved during a six-week pilot of the app, which involved 1,600 NSW Ambulance staff.

Research has shown that immediate chest compressions significantly improve survival rates for cardiac arrest patients.

The NSW Government has invested A$2.5m ($1.64m) in the GoodSAM project, in which individuals aged 18 years and older can register as responders without formal CPR training.

NSW Ambulance deputy commissioner David Dutton said: “Anyone who feels able to provide chest compressions can join, and the more people who register to be a GoodSAM responder, the better, because it increases the odds that someone nearby can provide immediate CPR and save a life if someone is in cardiac arrest.

“I’d like to thank the NSW Ambulance workforce for getting behind this programme and extend my appreciation to community members, staff and volunteers from our various partners, including other emergency services, NSW Government departments, volunteer organisations and NSW Health stakeholders, who have signed up in the lead up to today.”

Last week, NSW Minister for Health Ryan Park and the Minister for Mental Health Rose Jackson announced a one-time funding increase of A$50,000 for The Man Walk Australia, a men's mental health support service.

The funding aims to improve mental, physical and general wellbeing among men, including by introducing new walk locations in NSW.

Is it time for the healthcare sector to fully embrace the benefits of digitalization and AI?

Only a handful of approved therapeutic drugs are currently available for the treatment of ARF, all belonging to the solute carrier family 12 member 1 inhibitor. The clinical trial space in ARF consists of almost an equal mix of commercial as well as academic sponsors, with Iran and the US emerging as the key countries for conducting Phase III trials. While the current marketed drug space for ARF has only a handful of treatment options, currently available mid-to-late-stage pipeline drugs are likely to pave the way for a new treatment approach in the future.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close